• Home
  • Clinical value of measurable residual disease testing for assessing depth, duration, and direction of response in multiple myeloma.

Clinical value of measurable residual disease testing for assessing depth, duration, and direction of response in multiple myeloma.

Author List
Martinez-Lopez J, Wong SW, Shah N, Bahri N, Zhou K, Sheng Y, Huang CY, Martin T, Wolf J
Publication
Blood advances
Publication ID (Profile URL)
https://researcherprofiles.org/profile/126038650
Publication Year
2020
PubMed ID
32706892
Publication Title
Martinez-Lopez J, Wong SW, Shah N, Bahri N, Zhou K, Sheng Y, Huang CY, Martin T, Wolf J. Clinical value of measurable residual disease testing for assessing depth, duration, and direction of response in multiple myeloma. Blood Adv. 2020 07 28; 4(14):3295-3301.